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Genome-scale metabolic models (GEMs) can be used to evaluate genotype-phenotype relationships and
their application to microbial strain engineering is increasing in popularity. Some of the algorithms used
to simulate the phenotypes of mutant strains require the determination of a wild-type ﬂux distribution.
However, the accuracy of this reference, when calculated with ﬂux balance analysis, has not been studied
in detail before.
Here, the wild-type simulations of selected GEMs for Saccharomyces cerevisiae have been analysed
and most of the models tested predicted erroneous ﬂuxes in central pathways, especially in the pentose
phosphate pathway. Since the problematic ﬂuxes were mostly related to areas of the metabolism con-
suming or producing NADPH/NADH, we have manually curated all reactions including these cofactors by
forcing the use of NADPH/NADPþ in anabolic reactions and NADH/NADþ for catabolic reactions. The
curated models predicted more accurate ﬂux distributions and performed better in the simulation of
mutant phenotypes.
& 2016 Published by Elsevier B.V. on behalf of International Metabolic Engineering Society.1. Introduction
The application of Genome-Scale Metabolic Models (GEMs) to
the design and optimization of microbial strains is of great bio-
technological value and has been the topic of extensive research
(Garcia-Albornoz and Nielsen, 2013; Milne et al., 2009). The in-
terest in this topic has fuelled the development of numerous
computational methods that can simulate the ﬂuxes within GEMs
and search for combinations of genetic modiﬁcations that opti-
mize a desirable phenotypical trait (Kim et al., 2014; Lewis et al.,
2012; Xu et al., 2013). These strain engineering methods have been
applied to the optimization of the production of a range of dif-
ferent chemicals, which resulted in the construction of microbial
strains with improved phenotypes (Asadollahi et al., 2009; Bro
et al., 2006; Brochado et al., 2010; Choi et al., 2010; Fowler et al.,
2009; Otero et al., 2013).
Although the performance of in silico “inspired” strains is better
than the wild-type, the experimental production yields are often
below the simulated values. One of the factors that can affect the
quantitative reproducibility of the results obtained with strainlf of International Metabolic Engin
el; pFBA, parsimonious ﬂux
omass product coupled yield;engineering algorithms is the quality of the GEM. If a GEM does
not represent the full extent of the metabolic activities of the host
organism or contains errors, it might lead to inconsistencies be-
tween simulations and in vivo data.
GEMs are normally validated by testing their predictions of
core physiological parameters, such as the maximum growth yield
under different environmental conditions or the set of essential
genes in a particular condition (Edwards and Palsson, 2000; Feist
et al., 2007; Mo et al., 2009). The validation process rarely includes
the analysis of the intracellular ﬂuxes, even for models of well-
studied organisms, such as Escherichia coli and Saccharomyces
cerevisiae (Edwards and Palsson, 2000; Feist et al., 2007; Förster
et al., 2003; Mo et al., 2009). One of the possible reasons for the
lack of validation of GEMs at the ﬂux level might be the existence
of multiple objective functions to simulate ﬂux distributions,
which can yield different results for the same model and result in a
subjective quality assessment.
The accuracy of the ﬂuxes simulated with GEMs is of special
relevance when the simulation algorithms used for computing
mutant phenotypes require a reference (wild-type) ﬂux distribu-
tion, such as MOMA (Segrè et al., 2002), lMOMA (Becker et al.,
2007), ROOM (Shlomi et al., 2005) or MiMBL (Brochado et al.,
2012). Given the absence of ﬂux data at the genome scale, the
reference ﬂux distribution used by the algorithms stated above is
usually calculated using Flux Balance Analysis (FBA; Orth et al.,
2010) or parsimonious Flux Balance Analysis (pFBA; Lewis et al.,eering Society.
Fig. 1. Contextualization of the work described here within the workﬂow of in silico
strain design. Cited algorithms: MOMA (Segrè et al., 2002), LMOMA (Becker et al.,
2007), OptGene (Patil et al., 2005), BiMOMA (Kim et al., 2011).
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Consequently, given the lack of validation of GEMs at the ﬂux
prediction level, the reference ﬂux distributions calculated using
FBA/pFBA can contain ﬂux values that are not consistent with
in vivo values, which may compromise the subsequent phenotype
simulations. The sensitivity of phenotype simulations towards the
reference ﬂuxes has been demonstrated before for the MOMA al-
gorithm (Segrè et al., 2002), showing that even small deviations in
the wild-type ﬂux distribution can have an impact on the simu-
lation outcome. Furthermore, Brochado et al. (2012) also noted
that the reference ﬂux distribution had a signiﬁcant impact when
MiMBL was used to simulate single gene deletion mutants.
Therefore, it is of special interest to analyse the validity of ﬂux
distributions calculated with commonly used methods, such as
FBA/pFBA, in order to prevent inaccurate reference ﬂux distribu-
tions from affecting negatively the phenotypical predictions for
mutant organisms.
Besides the accuracy of the reference ﬂux distribution, there
are also other ways of improving the results of phenotype simu-
lation algorithms. For example, there is a group of simulation
methods that uses gene expression data to improve the simulation
accuracy (Machado and Herrgård, 2014). Methods such as RE-
LATCH (Kim and Reed, 2012) can analyse the changes in gene
expression between the wild-type and the mutant strain to infer
about the direction and magnitude of ﬂux changes expected.
However, these methods require gene expression data, for both
the wild-type and mutant organism, which reduces their appli-
cation to the simulation of strains that are already constructed and
characterized at the transcriptomic level.
Fig. 1 summarizes the steps required to perform simulations of
mutant phenotypes using algorithms that require a reference set
of ﬂuxes. As mentioned above, GEMs are usually not validated at
the ﬂux level and not much is known about the accuracy of the
reference ﬂux distributions obtained with FBA/pFBA. Therefore,
we propose that additional steps should be included in the in silico
strain engineering framework in order to verify the accuracy of the
ﬂux distributions used by the simulation algorithms. When the
ﬂuxes obtained are not consistent with the knowledge available
for a particular organism, further curation and validation of the
model should be performed.
S. cerevisiae is one of the most studied microorganisms and a
considerable amount of information about its metabolism is
available. It has proven to be quite versatile in terms of industrial
applications, making it very attractive for metabolic engineering.
Several GEMs have been published for S. cerevisiae over the last ten
years (Duarte et al., 2004; Förster et al., 2003; Herrgård et al.,
2008; Kuepfer et al., 2005; Mo et al., 2009; Nookaew et al., 2008;
Österlund et al., 2013) and their predictions of maximum growth
yield and exchange ﬂuxes using FBA is generally quite good. These
facts make S. cerevisiae very attractive for investigating in detail
the capacity of GEMs and simulation methods to predict the in-
tracellular ﬂux distribution of the central carbon metabolism.
Here we analysed the ﬂux distributions simulated with pFBA
for a selection of S. cerevisiae GEMs and veriﬁed that there are
considerable differences in the predicted ﬂuxes among the models
tested. The underlying causes for the differences observed were
traced back to the production and consumption of NADPH/NADH,
which led us to perform a detailed analysis and curation of all
reaction involved in the metabolism of these cofactors. Ad-
ditionally, we also investigated the impact of using different ﬂux
distributions on the simulation of mutant phenotypes. The pro-
duction of two organic acids was used as case-study to validate if
the improved ﬂux distributions affected the prediction of the si-
mulation algorithm. Overall, the improvements made to the me-
tabolism of NADPH resulted in phenotype simulations more con-
sistent with physiological data available in the literature, whichsupports the assumption that in silico strain design could beneﬁt
from additional validation steps as here proposed.2. Methods
2.1. Model retrieval and pre-processing
The models iFF708 (Förster et al., 2003) and iTO977 (Österlund
et al., 2013) were obtained in SBML format from the authors'
website (http://biomet-toolbox.org/index.php? page¼models-S.
cerevisiae). The model iMM904 (Mo et al., 2009) was downloaded
and converted to SBML using the script provided by the authors in
the supplementary material. Yeast 6.06 (Heavner et al., 2013) was
downloaded in SBML format from the project's website: http://
sourceforge.net/projects/yeast/ﬁles/.
Each model was imported into OptFlux 3.07 (Rocha et al., 2010)
and the in silico environmental conditions were set to mimic
minimal growth media supplemented with glucose under fully-
aerobic conditions (ammonia: unconstrained uptake, phosphate:
unconstrained uptake, sulfate: unconstrained uptake, oxygen:
unconstrained uptake, glucose: ﬁxed uptake of 1.15 mmol/
gCDW h).
2.2. Flux simulations
All simulations were executed within OptFlux 3.07 using IBM
ILOG CPLEX optimization studio (academic) as the linear pro-
gramming solver. The simulation method chosen to compute the
ﬂux distributions was pFBA (Lewis et al., 2010) and the objective
function was deﬁned as the maximization of the biomass
production.
In order to compare experimental ﬂux data with the simula-
tions it was necessary to create an equivalence map between the
main metabolic reactions present in central carbon metabolism
and the reactions of the models. Each model was inspected
manually to determine which reaction (or reactions) corresponds
to an enzymatic activity from the central metabolism. In genome-
scale metabolic models it is common to ﬁnd duplicated reactions
and other stoichiometrically equivalent pathways that catalyse the
same chemical transformation. The phosphorylation of glucose, for
example, can be carried by hexokinases or glucokinases. To sim-
plify the visualization of the ﬂuxes through the central metabolism
of S. cerevisiae, the ﬂuxes through equivalent reactions were
summed into a single value. Using the example above, all the re-
actions phosphorylating glucose to glucose-6-phosphate present
in each model were treated as a single entity. The equivalence map
for each of the models tested is provided in supplementary tables
S6 and S7.
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To verify the uniqueness of the ﬂux distributions calculated by
FBA, each reaction's variability was tested by ﬂux variability ana-
lysis (Burgard et al., 2001; Mahadevan and Schilling, 2003). Brieﬂy,
the value of the objective function (biomass growth) was ﬁxed at
its maximum and each target ﬂux was then minimized or max-
imized. However, since the models tested here contained many
reactions in the central metabolism that are duplicated, when one
of them is minimized the ﬂux could be routed through the other.
Furthermore, if the duplicated reactions are reversible, futile cycles
can arise. To avoid these irrelevant glitches in the analysis, when
one reaction's variability was tested, all the other “equivalent
partners” were disabled.
2.4. Optimizations of metabolic engineering targets
In order to search for strain designs with improved production
of acetate or mevalonate, the evolutionary optimization algo-
rithms included in OptFlux were used (Patil et al., 2005; Rocha
et al., 2008). The method selected to simulate the mutant phe-
notypes was the linear version (Becker et al., 2007) of the MOMA
algorithm (Segrè et al., 2002), where the Euclidian distance of the
ﬂuxes is replaced by the Manhattan distance. Two different phe-
notype objective functions were optimized by the evolutionary
algorithm: the Biomass Product Coupled Yield (BPCY; Patil et al.,
2005) or the maximization of the target ﬂux assuming a minimum
biomass growth threshold (YIELD). The evolutionary algorithm
was run at least three times for each target, setting the number of
solution evaluations to 50,000 and the maximum number of
knock-outs allowed to 5. In order to reduce the total number of
possible knock-out targets, the set of essential reactions and dead-
end reactions was not considered in the optimizations.3. Results and discussion
3.1. Comparison of genome-scale metabolic models
Since the ﬁrst GEM of S. cerevisiae was published in 2003
(Förster et al., 2003), several authors have expanded and improved
the metabolic reconstruction of this microorganism (reviewed by
Nookaew et al. (2011) and Osterlund et al. (2012)). Table 1 shows
the details for a selection of the GEMs available in the literature for
S. cerevisiae, focusing on model size and other relevant parameters.
The analysis of Table 1 reveals that over the years additional ORFs
and metabolic reactions were progressively included in the mod-
els, which resulted in models of increasing size. In comparison to
iFF708, the newer models include additional compartments and
some of them were balanced at the elemental level.
The validation of a GEM is usually performed using large-scale
gene essentiality data and/or extracellular ﬂux predictions (re-
viewed by Sánchez and Nielsen, 2015). Since the capability ofTable 1
Details of selected GEMs available for S. cerevisiae.
Model Year ORFs included Rea
iFF708 (Förster et al., 2003) 2003 708 117
iND750 (Duarte et al., 2004) 2004 750 148
iLL672 (Kuepfer et al., 2005) 2005 672 103
iIN800 (Nookaew et al., 2008) 2008 800 144
iMM904 (Mo et al., 2009) 2009 904 141
iTO977 (Österlund et al., 2013) 2013 977 156
Yeast 6 (Heavner et al., 2013) 2013 900 188
a Metabolic compartments refer to aqueous intracellular compartments, while the nthese models to predict the intracellular ﬂux distributions is rarely
analysed, it is hard to select the most suitable model for applica-
tions that require the computation of a reference set of ﬂuxes
(such as MOMA, ROOM, etc.). In order to clarify the suitability of
the GEMs of S. cerevisiae to predict the internal ﬂux distribution of
this microorganism, we selected four different models from Ta-
ble 1 (iFF708, iMM904, iTO977 and Yeast 6) and used them for
simulations with pFBA under the same environmental conditions.
iFF708 was chosen for this analysis because it is still widely used
for phenotype simulation purposes (Asadollahi et al., 2009; Bro
et al., 2006; Brochado et al., 2010; Otero et al., 2013), and the three
other models were chosen as they are the three most recent ones
(Table 1). The ﬂux values were taken from a pFBA simulation and
normalized to a glucose uptake rate of 100 arbitrary units.
When the models selected for analysis were simulated under
the same conditions it was noticeable that Yeast 6 was predicting a
maximum speciﬁc growth rate considerably higher than the oth-
ers (0.16 h1 vs. 0.11 h1). A detailed analysis of this problem re-
vealed that an unreasonably high ﬂux through the ATP synthase
was generating ATP without a corresponding input of NADH in the
oxidative phosphorylation pathway. This odd behaviour was
caused by a cycle of proton export from the mitochondria, origi-
nating from the aspartate:proton symporter (reaction r_1117 in the
model). By using a series of transporters and metabolic reactions,
Yeast 6 was capable of creating a proton gradient across the mi-
tochondrial membrane without any energy input. The solution to
this problem was to disable the activity of the aspartate:proton
symporter in the direction from the mitochondria to the cytosol.
Since under aerobic conditions there is a proton gradient across
the mitochondria membrane, the transport of aspartate is more
likely to occur in the direction of this gradient, i.e., from the cy-
tosol to the mitochondria. This issue allowed the ATP synthase to
be active even in the absence of oxygen, which can also explain
why it is necessary to manually disable this enzyme to obtain valid
anaerobic simulations with this model (Heavner et al., 2013). The
problem with the unconstrained transport of protons from the
mitochondria to the cytosol in the model Yeast 6 has been patched
in the most recent version of the Yeast consensus model (see re-
vision 7.11 in http://yeast.sourceforge.net/).
Using the amended Yeast 6 and the other models the ﬂux
distributions were computed and represented in a metabolic map
of the central metabolic pathways as shown in Fig. 2. One of the
most noticeable differences observed is the absence of ﬂux in the
oxidative Pentose Phosphate Pathway (PPP) in the most recent
models (iMM904, iTO977 and Yeast 6) in comparison to iFF708. An
analysis of the ﬂuxes revealed that in iTO977 and iMM904 all the
NADPH required for anabolic processes originated from the cyto-
solic NADP-speciﬁc isocitrate dehydrogenase, which is incon-
sistent with the role of the PPP in the production of this cofactor (it
is estimated that 26–44% of the total glucose that is consumed
enters the PPP [Gombert et al., 2001; Jouhten et al., 2008]). Re-
garding the Yeast 6 model, we observed that the main reaction
ﬁxing ammonia was the NADH-dependent glutamatections included Other information
5 3 compartments (2 metabolica)
9 8 compartments (7 metabolic), Elementally balanced
8 3 compartments (2 metabolic)
6 3 compartments (2 metabolic)
2 8 compartments (7 metabolic), Elementally balanced
6 4 compartments (3 metabolic)
8 15 compartments (7 metabolic), Elementally balanced
on-metabolic include the extracellular space and cellular membranes.
Fig. 2. Distribution of ﬂuxes in the central metabolism predicted by pFBA for the models: iFF708 (green), iMM904 (blue), iTO977 (orange) and Yeast 6 (black). The ﬂux values
shown are normalized to a glucose uptake rate of 100 arbitrary units. Growth rates for each model: iFF708–0.11 h1, iMM904–0.11 h1, iTO977–0.11 h1, Yeast 6–0.09 h1.
Reactions: ACONT- aconitase, ACS- acetyl-CoA synthetase, ADH- alcohol dehydrogenase, AKGD- alpha-ketoglutarate dehydrogenase, ALD- aldehyde dehydrogenase, CSm-
citrate synthase, FBA- fructose 1,6-bisphosphate aldolase, FUM- fumarase, G3PD1ir- glycerol-3-phosphate dehydrogenase, G3PT- glycerol-1-phosphatase, GAPD- glycer-
aldehyde-3-phosphate dehydrogenase, GHMT2r- serine hydroxymethyltransferase, GND- 6-phosphogluconate dehydrogenase, HEX- hexokinase, ICD- mitochondrial iso-
citrate dehydrogenase, MDH- mitochondrial malate dehydrogenase, ME- mitochondrial malic enzyme, PDC- pyruvate decarboxylase, PDH- pyruvate dehydrogenase, PFK-
phosphofructokinase, PGI- phosphoglucose isomerase, PGK- 3-phosphoglycerate kinase, PGMT- phosphoglucomutase, PP3- sum of the non-oxidative reactions of the
pentose phosphate pathway producing glyceraldehyde-3-phosphate, PP6- sum of the non-oxidative reactions of the pentose phosphate pathway producing fructose-6-
phosphate, PSP- phosphoserine phosphatase, PYC- pyruvate carboxylase, PYK- pyruvate kinase, SUCD- succinate dehydrogenase, SUCOAS- succinyl-CoA ligase, THRS-
threonine synthase, TPI- triose phosphate isomerase. Metabolites: 13dPG- 1,3-diphosphoglycerate, 3PG- 3-phosphoglycerate, AcCoA- acetyl-CoA, Akg- 2-oxoglutarate, Cit-
citrate, DHAP- dihydroxyacetone-phosphate, Fum- fumarate, G3P- glyceraldehyde-3-phosphate, Icit- isocitrate, Mal - L-malate, Oaa- oxaloacetate, Ser- L-serine, Succ-
succinate, SucCoa- succinyl-CoA.(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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shown). Furthermore, in Yeast 6, the NADPH required for most
anabolic processes was being produced by the cytosolic aldehyde
dehydrogenase and the cytosolic C1-tetrahydrofolate synthase.
The model comparison shown in Fig. 2 indicates that among
the tested models iFF708 shows the distribution of ﬂuxes most
consistent with ﬂux distributions of S. cerevisiae in glucose limited
chemostats (Gombert et al., 2001; Jouhten et al., 2008). In com-
parison to iFF708, the remaining models performed worst mostly
in the ﬂuxes related to NADPH metabolism. Therefore, in order to
improve the ﬂux accuracy of the most recent S. cerevisiae GEMs it
seems imperative to curate the areas of the metabolism involved
in NADPH production and consumption.
3.2. Model curation based on cofactor utilization
Given all the indications pointing towards problems with themetabolism of NADPH in the models of S. cerevisiae under analysis,
all the metabolic reactions involving this cofactor were collected
and their feasibility was examined. Since NADH can replace
NADPH as the electron donor in many reactions of S. cerevisiae, the
reactions where NADH was present were also included in the list
of reactions to be curated.
The curation process started by analysing one of the major is-
sues detected in the course of the model comparison, which was
the production of NADPH by the cytosolic isocitrate dehy-
drogenase in the models iMM904 and iTO977. The gene coding for
the cytosolic isocitrate dehydrogenase (IDP2) is known to be re-
pressed by glucose (Haselbeck and McAlister-Henn, 1993), but in
glucose-limited conditions, its activity might still be present.
Therefore, one cannot rule out the contribution of this gene to the
overall NADPH production based on regulatory phenomena alone.
The work of Satrustegui et al. (1983) has shown that the NADPH/
NADPþ ratio can also act as an inhibition factor for the cytosolic
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et al. (1983) reported that under growth on glucose the NADPH/
NADPþ ratio is high enough to inhibit the cytosolic isocitrate de-
hydrogenase of S. cerevisiae. In addition to this inhibitory effect, it
is also relevant to point out that the concentration of NADPH/
NADPþ can also affect the change in Gibbs free energy of this
reaction, which should favour the equilibrium in the direction of
NADPH consumption.
Assuming that the ﬁndings of Satrustegui et al. (1983) can be
generalized to other enzymes that use NADPH or NADH as cofac-
tors we curated manually all cytosolic reactions containing either
of these cofactors in the models under analysis. Since under fully-
aerobic glucose-limited conditions the ratio of NADPH/NADPþ is
usually high, in order to drive anabolic reactions, and the ratio of
NADH/NADþ is usually low, in order to promote fast metabolic
oxidation of the substrate (Canelas et al., 2008; Dijken and
Scheffers, 1986; Satrustegui et al., 1983; Voet and Voet, 2011), the
reversibility of cytosolic reactions should favour the consumption
of NADPH and the production of NADH. Therefore, most of the
reactions present in each model were constrained in the direction
of NADPH consumption and NADH production to enforce cofactor
availability constraints. The curation process is documented in the
supplementary Tables S1–S4 and the ﬁnal list of constrained re-
actions is shown in Table 2. The constraints from Table 2 are not
intended to be used as general revisions of the models tested here,
but rather as condition speciﬁc ﬂux bounds. Since the cofactor
abundance assumed in the curation process might not be valid for
other cultivation conditions, the ﬂux constraints should be used
exclusively for simulating wild-type S. cerevisiae in glucose limited
fully oxidative conditions.
During the manual curation process we observed that some of
the ﬂux constraints applied to enforce cofactor availability on the
S. cerevisiae models (Table 2) resulted in a lethal phenotype. The
inability to produce some biomass components after applying the
cofactor constraints was analysed in order to determine if the
observed phenotype was a consequence of a faulty model struc-
ture or misleading assumptions about the reaction's feasibility. For
iFF708 two constraints suffered from this issue: the inactivation of
the squalene epoxidase (model ID: ERG1) and the inactivation of
the cytosolic isocitrate dehydrogenase (model ID: IDP2_1). In the
ﬁrst case, ERG1 was inactivated because it could produce NADPH.
However, this reaction is described to consume NADPH (Leber
et al., 1998), supported by the fact that the other models all had
the correct stoichiometry. Therefore, we corrected the stoichio-
metry of ERG1 reaction in the model iFF708 and removed it from
the list of reactions to be inactivated. Regarding the lethal phe-
notype associated with the inactivation of the cytosolic isocitrate
dehydrogenase in iFF708, the reason for this behaviour was traced
back to the lack of mitochondrial transporters for 2-oxoglutarate.
Using the available knowledge about S. cerevisiae metabolism, we
added two transporters for 2-oxoglutarate to iFF708: citrate/2-
oxoglutarate antiporter (YHM2) and malate/2-oxoglutarate anti-
porter (ODC1, ODC2) (Castegna et al., 2010; Palmieri et al., 2001).
In the case of iMM904 a similar issue was encountered when
the cytosolic isocitrate dehydrogenase (model ID: R_ICDHy) was
inactivated. As before, the addition of the 2-oxoglutarate trans-
porters solved this issue and restored normal growth. However,
following the addition of these transporters there was an abnor-
mal increase in biomass formation caused by an artiﬁcial cycle of
proton export from the mitochondria, similar to the one observed
for the original Yeast 6 and discussed in Section 3.1. It was solved
by changing the reversibility of three mitochondrial transporters:
aspartate:proton symporter (model ID: R_ASPt2m), oxaloacetate:
proton symporter (model ID: R_OAAt2m) and mitochondrial di-
carboxylate carrier for L-malate (model ID: R_MALtm) were al-
lowed only to transport into the mitochondria. These changes
Fig. 3. Comparison between the original and curated ﬂux distributions for the models iFF708, iMM904, iTO977 and Yeast 6. A- Most relevant changes in the ﬂux distributions
of the curated models simulated with pFBA in comparison to two experimental ﬂux data sets obtained with 13C-Metabolic Flux Analysis of labelled glucose chemostats
(Gombert et al., 2001; Jouhten et al., 2008); B- comparison between the experimentally determined ﬂuxes (x-axis) and pFBA simulation of each model (y-axis). For each
graph it is shown: the linear regression equation, the correlation coefﬁcient (R2), the Spearman correlation coefﬁcient, the Pearson correlation coefﬁcient and the sum of
differences. The experimental ﬂuxes used in the correlations were obtained by averaging both sets of data (Gombert et al., 2001; Jouhten et al., 2008). The ﬂux values shown
are normalized to a glucose uptake rate of 100 arbitrary units. Abbreviations: ALD- aldehyde dehydrogenase, GDH1- NADPþ-dependent glutamate dehydrogenase, GDH2-
NADþ-dependent glutamate dehydrogenase, GND- 6-phosphogluconate dehydrogenase, ICDHc- cytosolic NADP-speciﬁc isocitrate dehydrogenase, ICDHm- mitochondrial
isocitrate dehydrogenase, OAAt- oxaloacetate transport from the cytosol to the mitochondria, PGI- phosphoglucose isomerase, TAL- Transaldolase, TKT1- transketolase (D-
xylulose-5P þ ribose-5P o-4 sedoheptulose-7Pþglyceraldehyde-3P), TKT2- transketolase (D-erythrose-4PþD-xylulose-5P o-4D-fructose-6Pþglyceraldehyde-3P).
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Regarding Yeast 6, the list of reactions to be inactivated also
included two candidates that were essential for growth: sterol
dehydrogenase (model ID: r_0234) and prephenate dehy-
drogenase (model ID: r_0939). In both cases, these reactions were
present in Yeast 6 as NADPþ dependent, but information from the
literature pointed to NADþ dependent versions (Baudry et al.,
2001; Mannhaupt et al., 1989). Thus, the alternative NADþ ver-
sions of both enzymes were introduced into Yeast 6, which solved
the lethal phenotypes observed.
Using the GEMs containing the ﬂux restrictions from Table 2and the corrections described above, we simulated again the ﬂux
distributions using pFBA and analysed the differences between the
curated models and the original ones (Fig. 3(A)). To serve as re-
ference values we also included in Fig. 3(A) two sets of experi-
mentally determined ﬂux values obtained with 13C-Metabolic Flux
Analysis of labelled glucose chemostats (Gombert et al., 2001;
Jouhten et al., 2008). Fig. 3(A) shows that the curation process
resulted in an increase in the oxidative PPP ﬂux (GND) in all
models, which was more dramatic in iMM904, iTO977 and Yeast 6.
Furthermore, there were also other improvements in reactions
related to NADPH/NADH metabolism. The complete set of central
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under analysis.
Focusing the analysis on iFF708 (Fig. 3(A)), there was an in-
crease in the ﬂux through the oxidative PPP to levels closer to the
experimental ﬂuxes. This increase was a consequence of an extra
consumption of NADPH for anabolic purposes. Since many of the
anabolic reactions present in the original iFF708 can consume ei-
ther NADH or NADPH, when the NADH consuming partners were
constrained (Table 2) the cell had to synthesize essential biomass
components using NADPH as an electron donor. As a consequence,
the ﬂux through the PPP had to compensate for the increased
requirements for this cofactor. Another visible difference is the
increased transport of oxaloacetate into to the mitochondria
(OAAt), which can be explained by the inactivation of the cytosolic
isocitrate dehydrogenase (ICDHc) and the addition of the mi-
tochondrial 2-oxoglutarate transporters. These modiﬁcations
shifted 2-oxoglutarate production from the cytosol to the mi-
tochondria, resulting in an increase in the anaplerotic ﬂux of ox-
aloacetate into the mitochondria.
Regarding iMM904, one of the most noticeable problems ob-
served in the model comparison (Fig. 2) was the lack of ﬂux in the
oxidative PPP. As shown in Fig. 3(A), in the curated iMM904 the
ﬂux through the oxidative PPP (GND) increased dramatically in
comparison to the original model and the simulated ﬂux value is
within the interval of values determined experimentally (Gombert
et al., 2001; Jouhten et al., 2008). The modiﬁcation that con-
tributed the most to the improvement observed in the oxidative
PPP was the deactivation of the cytosolic isocitrate dehydrogenase
(ICDHc), which shifted NADPH production to the PPP. As a con-
sequence of the increase in ﬂux in the oxidative PPP, the ﬂuxes in
the non-oxidative PPP (TAL, TKT1 and TKT2) changed direction
when compared to simulations of the original model and became
consistent with the experimental ﬂux data. There was also an
improvement in the mitochondrial isocitrate dehydrogenase
(ICDHm) as a consequence of the deactivation of the cytosolic
isocitrate dehydrogenase in conjunction with the introduction of
the 2-oxoglutarate transporters.
Similarly to iMM904, iTO977 also showed improvements in PPP
and citric acid cycle. In this case, the reason for the zero ﬂux
through the PPP was solely the activity of the cytosolic isocitrate
dehydrogenase (ICDHc), which was supplying all the NADPH re-
quired for growth. Furthermore, this issue was also responsible for
the low ﬂux through mitochondrial isocitrate dehydrogenase
(ICDHm). Consequently, the cofactor constrains applied to the
model solved both of these problems (Fig. 3(A)).
In the case of Yeast 6, the curated model showed improvements
on several pathways, which included the PPP, transport of ox-
aloacetate and in the ammonium assimilation. Similarly to the
other models, the increase in the oxidative part of the PPP (GND) is
one of the most prominent differences in comparison to the ori-
ginal model simulation. Additionally, the non-oxidative reactions
of the PPP (TAL, TKT1 and TKT2) changed direction in comparison
to the original model and became consistent with experimental
ﬂux values. Another considerable difference between the original
and curated models is the cofactor usage by the glutamate dehy-
drogenase reaction. After the curation process, the cofactor used in
the glutamate dehydrogenase reaction changed from NADH
(GDH2) to NADPH (GDH1), which increased the requirements for
NADPH considerably. The preference of S. cerevisiae for the NADPH
dependent glutamate dehydrogenase is consistent with the im-
portance of this enzyme in vivo (Avendaño et al., 1997; Dubois
et al., 1974). We also observed an improvement in the prediction of
the ﬂux of oxaloacetate into the mitochondria in the curated
model (OAAt) and a decrease in the cytosolic aldehyde dehy-
drogenase (ALD), which was the source of NADPH in the simula-
tions made for the original model.In order to analyse quantitatively the improvements observed
in the curated models, we plotted the simulated ﬂuxes against the
corresponding experimental values in Fig. 3(B) and analysed sta-
tistically the correlation between them. For the revised iFF708
model all the parameters analysed improved slightly with the
exception of the Spearman coefﬁcient. The modest improvements
observed for the curated iFF708 are consistent with the fact this
model had the best initial ﬂux distribution. However, for the other
three models the improvements are much more pronounced, and
in all cases the correlation coefﬁcients show that the curation
process resulted in a much better prediction of metabolic ﬂuxes in
the central metabolism.
Given the non-uniqueness of the FBA/pFBA simulations, it is
possible that the ﬂux distributions computed with these methods
suffer from variability even when the objective function is at its
optimal value. Therefore, the ﬂux changes analysed in this
section could have been a consequence of ﬂux variability and
not related with the curation process undertaken. In order to test
this, we performed Flux Variability Analysis (Burgard et al., 2001;
Mahadevan and Schilling, 2003) for each ﬂux shown in Fig. 2.
The ﬂuxes that showed more than 10% variation in comparison
to the value obtained with pFBA are listed in supplementary
Table S5. The analysis of the variable ﬂux values showed
that the changes observed between the original and curated
models were a consequence of the constraints applied. A thorough
analysis of the variable ﬂux values is given in supplementary
Text S1.
The genome-scale models modiﬁed in this study are provided
in supplementary material in SBML format. Two versions of each
model are supplied: one version includes general corrections of
the problems we encountered in each model during the curation
process and another version with all the cofactor constrains shown
in Table 2.
3.3. Additional ﬂux inconsistencies
After the manual curation process, some of the ﬂuxes in the
central carbon metabolism were still incorrectly simulated by
pFBA. One of such cases was the absence of ﬂux through the
normal pathway for L-threonine production in the model iTO977
(THRS in supplementary Fig. S1). The absence of ﬂux in this
pathway was caused by the existence of an alternative route for
L-threonine production using a threonine aldolase reaction that
converts glycine and acetaldehyde to L-threonine in this model
(model ID: GLY1). Although the threonine aldolase reaction is
present in all models, only in iTO977 it can occur in the direction
of L-threonine production. This reaction is reported in the litera-
ture as a possible source of glycine in S. cerevisiae (McNeil et al.,
1994; Monschau et al., 2006), but it has not been reported yet that
it can also act as a source of L-threonine. In fact, S. cerevisiae be-
comes auxotrophic for L-threonine when threonine synthase is
inactivated (Kingsbury and McCusker, 2010; Mannhaupt et al.,
1990), which suggests that the threonine aldolase cannot act as an
L-threonine source in this organism.
In the model Yeast 6 we also detected an issue regarding the
synthesis of acetyl-CoA in the cytosol. As shown in supplementary
Fig. S1, no ﬂux is predicted through acetyl-CoA synthetase (ACS in
supplementary Fig. S1), which seems strange given the essentiality
of acetyl-CoA synthesis in the cytoplasm. Again, an erroneous re-
versibility was responsible for this problem: the cytosolic acetyl-
CoA hydrolase (model ID: r_0110) was able to catalyse the reverse
reaction, joining acetate and coenzyme A without an energy input.
This enzyme is reported to be located in the mitochondria and
there is no indication that it can catalyse the ligation of acetate and
coenzyme A (Fleck and Brock, 2009).
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tant phenotypes
Among the simulation methods available to compute the
phenotype of a mutant organism using GEMs, there is a group
which assumes that the mutant cell will try to minimize the
magnitude of its adaptation in comparison to the wild-type.
Within this group of simulation methods there are several alter-
natives, such as MOMA (Segrè et al., 2002), lMOMA (Becker et al.,
2007), ROOM (Shlomi et al., 2005) or MiMBL (Brochado et al.,
2012), which differ in the metric used for minimising the distance
between the wild-type and the mutant cell. These simulation al-
gorithms require a reference distribution of ﬂuxes to be used as an
indication of the metabolic status in the wild-type organism and a
few studies have indicated that the simulation results of MOMA
and MiMBL are sensitive to the set of ﬂuxes used as reference
(Brochado et al., 2012; Segrè et al., 2002).
Since the simulation methods mentioned above rely on a set of
reference ﬂuxes for their computations, their results might be af-
fected by the inaccurate ﬂuxes discussed in Section 3.1. To test
how the improvements observed in the curated ﬂux distributions
(Section 3.2) would perform in comparison to the original ones,
we used the model Yeast 6 and the lMOMA algorithm (Becker
et al., 2007) to compute the phenotype of strains obtained for the
production of two organic acids, acetate and mevalonate.
In order to obtain strains with increased production in silico of
acetate and mevalonate we used the evolutionary algorithm in-
cluded in OptFlux to search for sets of optimal knock-outs. During
the optimization process we used the curated ﬂux distribution as a
reference but the original reaction constraints were kept un-
changed. Since some of the knock-outs implemented during the
optimization process could alter the abundance of NADPH or
NADH, the ﬂux constraints derived from the curation process
(Table 2) might not be applicable to the mutant strains simulated.
Table 3 shows a selection of the strain designs obtained with
OptFlux for the optimization of mevalonate and acetate produc-
tion by using the improved ﬂux distribution as a reference during
the strain optimization process. One strain design for each case
study is presented in Table 3, with detailed information about the
gene knock-outs necessary to achieve the corresponding produc-
tion yields. The results shown for the original reference were ob-
tained by simulating the same strain designs with the ﬂux dis-
tribution for Yeast 6 show in Fig. 2.
As shown in Table 3, the mevalonate producing mutant ob-
tained in the optimization procedure required the inactivation of
three different metabolic reactions (corresponding to four genes)
to achieve a yield of 0.056 g mevalonate/g glucose. A detailed in-
spection of the changes in the ﬂux distribution (Fig. 4) revealed
that the deletion of the NADPH-dependent glutamate dehy-
drogenases (GDH1 and GDH3) causes a surplus in the availability of
NADPH. The deletion of the NADþ-dependent 5,10-methylenete-
trahydrafolate dehydrogenase (MTD1) is necessary to avoid theTable 3
Impact of ﬂux distributions in the performance of strain designs obtained with OptFlux
deleted genes are shown in bold).
Target Inactivated reactions
Mevalonate MTD1: NADþþ5,10-methylene-THF -4 NADH þ5,10-me
LSC1 or LSC2: ADP(m)þ HPO42-(m)þ Succinyl-CoA(m) -4
GDH1 and GDH3: Hþþ NH4þ NADPH þ2-oxoglutarate -
Acetate ZWF1: D-glucose-6-phosphate þ NADPþ -4 Hþþ NAD
IDP2: NADPþþ Isocitrate -4 CO2þ NADPH þ2-oxogluta
GDH2: NADþþ H2O þL-glutamate o-4 Hþþ NADH þ
AAT2: L-aspartate þ2-oxoglutarate o-4L-glutamate þtransfer of electrons from NADPH to NADþ , forcing the excess of
NADPH to be used elsewhere. With the inactivation of the succi-
nyl-CoA synthetase (gene name - LSC1, ID in Fig. 4 - SUCOAS) the
citric acid cycle is broken and part of the ﬂux is redirected to
pyruvate decarboxylase (PDC), which originates an excess of
acetyl-CoA that is re-assimilated using the enzymes from glyox-
ylate cycle. Furthermore, this deletion also causes an excess of
acetyl-CoA in the mitochondria, which can be condensed into
hydroxymethylglutaryl-CoA (HMGCoa) and transported to the
cytosol. In that compartment, this metabolite can be converted to
mevalonate while consuming NADPH, which alleviates the excess
of this cofactor. In summary, two deletions are required to increase
the amount of NADPH available in the cytosol, while the other
increases the ﬂux to hydroxymethylglutaryl-CoA (precursor of
mevalonate). If the original reference ﬂux distribution would be
used in the phenotype simulation, the amount of mevalonate ex-
creted by this mutant would be around seven times lower (Ta-
ble 3), which shows the impact of the reference distribution of
ﬂuxes in phenotype simulation. The differences observed in the
mevalonate yield are a consequence of the dependence of the
mevalonate production on an engineering strategy based on
NADPH availability.
Experimental evidence is available in the literature to support
part of the strategy presented here for in silico mevalonate pro-
duction. The inactivation of GDH1 was implemented by Nissen
et al. (2000) to alter cofactor abundance in anaerobic conditions to
decrease glycerol accumulation. Furthermore, Scalcinati et al.
(2012) also used the GDH1 deletion to increase the abundance of
NADPH and consequently boost the ﬂux through the mevalonate
pathway as part of a metabolic engineering strategy to increase α-
santalene production. The production of cubebol also beneﬁted
from the increased NADPH pool resulting from GDH1 deletion
(Asadollahi et al., 2009). Given the experimental evidences sup-
porting the in silico predictions, it seems that the improved re-
ference ﬂux distribution is much better to represent the metabo-
lism of the wild-type S. cerevisiae, especially in areas related to
NADPH production/consumption.
Regarding the acetate producing mutant, there is also a con-
siderable difference in the acetate yield depending on which re-
ference ﬂux distribution is used (Table 3). A quick analysis of the
gene deletions required to induce acetate production revealed
that, similarly to the mevalonate producing mutant, NADPH me-
tabolism is also involved in this case. However, in this case the key
to produce acetate in silico is forcing the cytosolic NADPþ-de-
pendent aldehyde dehydrogenase (gene name – ALD6, ID in Fig. 4 -
ALD) to be the source of cytosolic NADPH (Fig. 4).
To reach the acetate producing phenotype, glucose-6-phos-
phate dehydrogenase (gene name – ZWF1, ID in Fig. 4 - GND) must
be deleted so that the oxidative PPP becomes inactivated. Since
this pathway is the main source of NADPH in the cytosol, the
metabolic network has to adapt to the lack of this cofactor by
activating other possible production sources. Furthermore, the listfor mevalonate and acetate production using lMOMA (the standard names of the
Product yield (g/g glucose)
thenyl-THF
CoA(m)þ Succinate(m)þ ATP(m)
4 H2O þL-glutamate þ NADPþ
Corrected reference: 0.056
Original reference: 0.0075
PH þ6-phosphogluconolactone
rate
NH4þ2-oxoglutarate
Oxaloacetate
Corrected reference: 0.045
Original reference: 0.0
Fig. 4. Flux distributions simulated with lMOMA for the mevalonate mutant (A) and the acetate mutant (B) using the improved ﬂux distribution as the reference. The wild-
type ﬂux values are shown in green, the mutant values are shown in red and the knock-outs are signalled by a red cross. The ﬂux values shown are normalized to a glucose
uptake rate of 100 arbitrary units. Reactions: ACONT- aconitase, ADE3- cytosolic C1-tetrahydrofolate synthase, AKGD- alpha-ketoglutarate dehydrogenase, ALD- aldehyde
dehydrogenase, CSm- citrate synthase, FBA- fructose 1,6-bisphosphate aldolase, FUM- fumarase, GAPD- glyceraldehyde-3-phosphate dehydrogenase, GDH1/3- NADPþ-
dependent glutamate dehydrogenase, GDH2- NADþ-dependent glutamate dehydrogenase, GND- 6-phosphogluconate dehydrogenase, HEX- hexokinase, HMG1- HMG-CoA
reductase, ICD- mitochondrial isocitrate dehydrogenase, ICL- isocitrate lyase, IDP2- cytosolic NADP-speciﬁc isocitrate dehydrogenase, MALS- malate synthase, MDH- mi-
tochondrial malate dehydrogenase, ME- mitochondrial malic enzyme, MTD1- NAD-dependent 5,10-methylenetetrahydrafolate dehydrogenase, PDC- pyruvate decarboxylase,
PDH- pyruvate dehydrogenase, PFK- phosphofructokinase, PGI- phosphoglucose isomerase, PGK- 3-phosphoglycerate kinase, PGMT- phosphoglucomutase, PP3- sum of the
non-oxidative reactions of the pentose phosphate pathway producing glyceraldehyde-3-phosphate, PP6- sum of the non-oxidative reactions of the pentose phosphate
pathway producing fructose-6-phosphate, PYC- pyruvate carboxylase, PYK- pyruvate kinase, SUCD- succinate dehydrogenase, SUCOAS- succinyl-CoA ligase, THRS- threonine
synthase, TPI- triose phosphate isomerase; Metabolites: 13dPG- 1,3-diphosphoglycerate, 3PG- 3-phosphoglycerate, AcCoA- acetyl-CoA, Akg- 2-oxoglutarate, Cit- citrate,
DHAP- dihydroxyacetone-phosphate, Fum- fumarate, G3P- glyceraldehyde-3-phosphate, Glx- glyoxylate, Icit- isocitrate, HMGCoa- 3-hydroxy-3-methylglutaryl-CoA, Mal -
L-malate, Oaa- oxaloacetate, Succ- succinate, SucCoa- succinyl-CoA. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web
version of this article.)
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isocitrate dehydrogenase (IDP2), which can also be a possible
source of NADPH for the cell. The ﬁnal two deletions act on the
other side of NADPH metabolism, i.e., on possible sinks of this
cofactor. The deletion of the NADH-dependent glutamate dehy-
drogenase (GDH2) is necessary to “force” the use of the NADPH
dependent enzyme (GDH1/GDH3) for ammonium assimilation.
With the same goal, deleting the cytosolic aspartate amino-
transferase (AAT2) also increases the ﬂux through the NADPH
dependent glutamate dehydrogenase. As shown in Fig. 4, all four
deletions trigger rearrangements on the NADPH metabolism that
culminate in an increased ﬂux through the cytosolic NADPþ-de-
pendent aldehyde dehydrogenase (gene name – ALD6, ID in Fig. 4 -
ALD). Since this reaction becomes the main source of NADPH in
the cytosol, the extra ﬂux results in acetate accumulation.
Experimental data regarding the inactivation of the glucose-6-
phosphate dehydrogenase (ZWF1) in S. cerevisiae has shown that
this knock-out can decrease the availability of cytosolic NADPH,
resulting in reduced growth on glucose minimal medium (Blank
et al., 2005), methionine auxotrophy (Thomas et al., 1991) and
increased sensitivity to oxidizing agents (Nogae and Johnston,
1990). In the absence of the glucose-6-phosphate dehydrogenaseit has been shown that the cytosolic NADP-speciﬁc isocitrate de-
hydrogenase (IDP2) can also fulﬁl the NADPH production role
(Minard and McAlister-Henn, 2005). Furthermore, the over-
expression of the cytosolic NADPþ-dependent aldehyde dehy-
drogenase (ALD6) has been demonstrated to solve the methionine
auxotrophy by increasing the availability of cytosolic NAPDH
(Grabowska and Chelstowska, 2003). The compensation between
the enzymes mentioned above, as the cytosolic NADPH source,
supports the behaviour of the acetate producing mutant in Table 3
and indicates that the model is predicting accurately the NADPH
metabolism when the curated ﬂux distribution is used.4. Conclusions
In conclusion, we observed that the oldest GEM of S. cerevisiae
(iFF708) showed the best prediction of central carbon ﬂuxes. This
fact might be explained by extra validation and curation steps
performed during its construction (Förster et al., 2003). iFF708 is
still preferred by many authors in metabolic engineering projects
over the more recent GEMs because of its better description of
ﬂuxes in the central metabolism (Asadollahi et al., 2009; Bro et al.,
R. Pereira et al. / Metabolic Engineering Communications 3 (2016) 153–1631622006; Brochado et al., 2010; Otero et al., 2013).
The results presented here, showed that the ﬂux distributions
of the newer GEMs could be signiﬁcantly improved by imposing
ﬂux constraints on reactions involved in the metabolism of NADPH
and NADH. The changes applied to cofactor metabolism had the
most impact on central metabolic ﬂuxes related to NADPH meta-
bolism, especially in the oxidative PPP. The reactions involved in
the production of NADH were not as affected by the imposed
constraints because the simulations of the original models were
quite good in this regard. The better predictions of NADH meta-
bolism were most likely a consequence of the central role of this
metabolite for ATP production in the oxidative phosphorylation.
Since the cofactor constraints proposed here revealed that si-
milar ﬂux distributions can be obtained with more recent models,
it is now possible to take advantage of better compartmentaliza-
tion, elementally balance reactions and increased genome cover-
age, without sacriﬁcing the quality of ﬂuxes in the central meta-
bolism. This work also showed that the application of GEMs for
strain simulation/design using algorithms that require a reference
ﬂux distribution should be preceded by a careful validation of the
model predictions of the ﬂuxes for the wild-type organism.Acknowledgements
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